US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 
Region: All Regions > Europe > Switzerland
Category: All Categories > Life Sciences > Pharmaceuticals > Country Overviews
(8 reports matching your criteria)
Pharmaceuticals and Healthcare Report - Switzerland Q3 2014
6/11/2014 | published by: Business Monitor International
... consumption levels (as a result of an ageing population) and the population's preference for high-value innovative treatments for chronic diseases over lower-value generic medicines. The government operates a generous medicine reimbursement scheme and the country ...  |  read more...
USD 1,295
Switzerland Pharmaceuticals and Healthcare Report Q2 2014
3/19/2014 | published by: Business Monitor International
... into greater demand for drugs. Furthermore, the country's highly developed infrastructuremeans that access to healthcare is easy, further supporting the consumption of medicines. Headline Expenditure Projections Pharmaceuticals: CHF7.19bn (US$7.76bn) in 2013 to CHF7.33bn (US$6.84bn) in ...  |  read more...
USD 1,295
Switzerland Pharmaceuticals and Healthcare Report Q4 2012
10/3/2012 | published by: Business Monitor International
... believes the government needs to do more to alter patients'attitudes towards these drugs as this the main deterrent of growth. Headline Expenditure Projections Pharmaceuticals: CHF6.77bn (US$7.63bn) in 2011 to CHF6.58bn (US$7.00bn) in 2012; -2.8%decline in ...  |  read more...
USD 1,175
Switzerland Pharmaceuticals and Healthcare Report Q3 2012
7/10/2012 | published by: Business Monitor International
... prompt local companies to get more involved in the segment. According to data published by Swissmedic, Sandoz Pharmaceuticals, Novartis's generic medicines arm, has 556 preparations locally approved, while Teva has 345 preparations locally approved. However, ...  |  read more...
USD 1,175
Switzerland Pharmaceuticals and Healthcare Report Q2 2012
3/20/2012 | published by: Business Monitor International
... a result of the increased prevalence of chronic disease with age, thereforeconsuming a disproportionately large share of healthcare services. Such robust demand for services overthe coming years means the government will need to adapt strategies ...  |  read more...
USD 1,175
Switzerland Pharmaceuticals and Healthcare Report Q1 2012
2/28/2012 | published by: Business Monitor International
... sector. Prescription drug spending accounted for 76% of total drug spending in 2010 and public expenditure on health accounted for 58% of total spending on healthcare. Headline Expenditure Projections Pharmaceuticals: CHF5.88bn (US$5.64bn) in 2010 to ...  |  read more...
USD 1,175
The Pharmaceutical Market: Switzerland (pdf/xls)
2/17/2012 | published by: Espicom Healthcare Intelligence
... for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the ...  |  read more...
USD 1,085
Pharmaceuticals - Switzerland
9/1/2011 | published by: Global Research & Data Services
... in Switzerland, 2004-2010 Market for pharmaceuticals by type Forecasts and future outlook of the market till 2016 Country overview, macroeconomic indicators and indicators of doing business  The market analysis discusses the following types of pharmaceuticals:  ...  |  read more...
USD 654